Blood Processing Devices and Consumables Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Blood Processing Devices (Blood Cell Processors, Blood Grouping Analyzers, Blood Bank Freezers and Refrigerators, Blood Warmers, Hematocrit Centrifuges, Others) Blood Processing Consumables (Blood Grouping Reagents, Slides, Blood Administration Sets, Coagulation Reagents, Blood Filters, Blood Lancets, Blood Bags, Blood Collection Tubes, Sedimentation Tubes, Others)), By End User (Hospitals, Clinics, Blood Banks, Research Centers, Others) and Region Forecast 2019-2030

Blood Processing Devices and Consumables Market size was valued at US$ 35,129.6 million in 2023 and is poised to grow at a CAGR of 7.2% from 2024-2030. The process of transfer the blood or blood products into one circulation intravenously known as blood transfusion. Early transfusions generally used whole blood transfusion, but advancements in technology, able to transfuse blood components such as RBC, plasma and platelets. After the collection of blood before the transfusion, the blood is stored and processed to make sustainable for use in the specific patient population. Various devices and consumables are used in storage and processing the blood. The devices are used such as refrigerators to maintain the temperature, blood component separating devices such as centrifugation devices and others. Consumables are vials, storage pockets, blood grouping reagents and others.

The global blood processing devices and consumables market have plenty of market players and it is consolidated. In terms of processing devices, strong market players are present. Companies are focused on new product developments and market expansions to strengthen their market share. For instance, in August 2015, Bio-Rad Laboratories, Inc. launched the IH-500, a fully automated random access system for blood typing and screening. Furthermore, companies are also strengthening position by acquiring the other companies operating in same market. For instance, in Agust 2012, Haemonetics Corporation acquired business assets of blood collection, filteration and processing product lines of Pall Corporation.